Given that TSA treatment reversed the hippocampal expression of GR in adult MS rats, we tested the activation of NF-κB signaling and neuroinflammatory responses to sevoflurane in TSA—and vehicle-treated MS rats. This evidence concerns the gene NFKB1 and myeloid sarcoma.